Rabies is a zoonotic viral disease caused due to animal bites. The disease is mainly transmitted from domestic and wild animals such as bats, foxes, raccoons, cats, or dogs and infects humans upon contacting infected animal saliva. Its incubation period is of one to three months. Several symptoms are shown in individuals suffering from rabies, such as fever and pain or burning sensation (paraesthesia) at the wound site. One of the approved and effective methods against rabies is rabies immunoglobulin, i.e., a medication made up of antibodies against the rabies virus to prevent rabies.
The "Global Rabies Immunoglobulin Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the rabies immunoglobulin market with detailed market segmentation by type, application, and geography. The report provides key statistics on the market status of the leading rabies immunoglobulin market players and offers key trends and opportunities in the market.
Based on type, the global rabies immunoglobulin market is segmented into ERIG and HRIG.
Based on application, the market is segmented into category II exposure and category III exposure.
MARKET DYNAMICS Drivers:
The rising geriatrics population, increasing prevalence of target diseases, and rising cases of rabies drive the rabies immunoglobulin market growth.
Growing development of effective human rabies immunoglobulin and rising preference for point-of-care testing boost market growth.
Growing government initiatives fuel market growth.
Absence of a predefined regulatory framework.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The rabies immunoglobulin market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the rabies immunoglobulin market in these regions.
IMPACT OF COVID-19 ON RABIES IMMUNOGLOBULIN MARKET
COVID-19 first began in Wuhan (China) during December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. The COVID-19 pandemic had affected the growth of the market. As per the data of the CDC, 2020, several animals, including cats, dogs, and a few other types of animals, were at potential risk of acquiring the virus. Therefore, a study was conducted that showed the rapid development of a novel, highly efficient, and safe COVID-19 vaccine via a rabies virus-based vector which proved to be an efficient vaccine against several emerging infectious diseases. Hence, the market growth was surged due to these developments during the pandemic.
Get more information on this report :
The report covers key developments in the rabies immunoglobulin market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market players from rabies immunoglobulin market are anticipated to have lucrative growth opportunities in the future with the rising demand for rabies immunoglobulin in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the rabies immunoglobulin market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
Sichuan Yuanda Shuyang
Vins Bioproducts Limited.
Bio Products Laboratory Limited
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.